[99mTc]Tc-DB8
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [99mTc]Tc-DB8, covering 2025-12-22 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: [99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression [Phase 2]